The Biotechnology Science Coordinating Committee (BSCC), at the behest of the White House Office of Science and Technology Policy (OSTP), held the first of three public meetings to discuss an update to the coordinated framework which serves as the regulatory guidelines for genetically engineered organisms. This meeting provided an opportunity for representatives from the primary agencies involved in GMO regulation, the Food and Drug Administration (FDA), Environmental Protection Agency (EPA), and US Department of Agriculture (USDA) to clarify their roles in the current framework.

Dr. John P. Holdren, Senior Advisor to President Barack Obama and Director of OSTP, opened the meeting, providing the history behind the formation of the coordinated framework and citing rapid advances in the field of gene editing as the impetus to update regulations and speed innovation. The Assistant Director for Biological Innovation at OSTP, Dr. Roberto Barbero delved deeper into the intentions behind the call to update the coordinated framework, highlighting the need to improve transparency in the regulatory process and engage the best scientific evidence as a part of the deliberations. Further, Barbero reiterated the need to support research science that underpins regulatory strategy to maintain evidence-based decision making.

Following OSTP’s introduction, Dr. John Turner, Director of the Biotechnology Risk Analysis Program in the Animal and Plant Health Inspection Service (APHIS) at USDA cited the Plant Protection Act of 2000 as the enabling authority to regulate genetically engineered plants that have a “plant pest component” with the goal of protecting plants and plant products from pests. The animal component of USDA oversight was presented by Dr. Lisa Ferguson, National Director of Policy Permitting and Regulatory Services in APHIS-Veterinary Service. Ferguson demonstrated the USDA authority over genetically engineered animals through the Animal Health Protection Act, specifically refers to the import of animals, the interstate movement of animals infected with certain diseases, and insects which are vectors of animal diseases. To simplify the charge, Ferguson asserted the agency’s goal to regulate anything that might impact the health of US livestock.

The EPA sent two representatives to explain the agency’s role in the coordinated framework to regulation biotechnology. Mike Mendelson, Senior Regulatory Specialist in the Microbial Pesticides Branch of the Office of Pesticides Programs, Biopesticides and Pollution Prevention, began the segment by referencing four key laws that govern the activities his office: Federal Insecticide, Fungicide, and Rodenticide Act; Federal Food, Drug, and Cosmetic Act; Food Quality Protection Act; and the Pesticide Registration Improvement Act. Most relevant to the discussion of genetically engineered organisms are “plant incorporated protectants,” defined as any pesticide substance intended to be produced and used in a living plant and the genetic material necessary for the production of such pesticidal substance. The regulatory reach of EPA also encompasses pesticidal products, such as the Bt Cry1Ab protein and the cry1Ab gene found in Bt corn. Underscoring the need for coordination among federal agencies for pesticides, Mendelson distilled the framework, stating the EPA ensures an organism is safe for use as a pesticide, FDA ensures an organism is safe for use in food and feed, and USDA ensures an organism is safe for agriculture and the environment.

Dr. Mark Segal, Senior Microbiologist in the Office of Pollution Prevention and Toxics at the EPA described the gap-filling function of the Toxic Substances Control Act of 1976. This legislation gave the EPA the authority to regulate the manufacture, use, distribution in commerce, and disposal of chemical substances and mixtures. The oversight includes microorganisms constructed with synthetic genes that are not identical to DNA that would be derived from the same genus as the recipient. Biomass conversion for chemical production, microbial fuel cells, and non-pesticidal agriculture are among the biotechnology products under the purview of the Toxic Substances Control Act. Segal noted that the proposed update to the coordinated framework was timely, as new technologies have byproducts that are excluded from oversight and require “new potential interactions between regulatory agencies that were not anticipated when the framework was published.”

The final presentation was given by Leslie Kux, Associate Commissioner for Policy at the FDA, who referenced the Food and Drug Cosmetic Act‘s provision to ensure the safety of adulterated foods and food additives. Kux noted that transferred genetic material and the intended expression products could be subject to food additives regulations, unless the material and intended products are deemed “generally recognized as safe.” In a 1992 statement, FDA stated “that the regulatory status of a food, irrespective of the method by which it is developed, is dependent upon the objective characteristics of the food.” Stated plainly, the FDA regulates the product of genetic engineering and not the process. In an effort to ensure the safety of genetically engineered foods, the FDA has implemented a pre-market consultation process whereby companies work with the FDA to address all safety and regulatory issues prior to a product coming to market. As a result, over 150 genetically engineered plant varieties that were subject to this consultation process were generally recognized as safe once they were  available to the public, and therefore not regulated by the FDA.

Kux also provided an overview of new animal drug provisions, which prohibit the introduction of unapproved drugs into commerce. This covers all genetically engineered animals bearing heritable rDNA constructs including biopharm animals. Such cases are evaluated by a risk-based approach where applicants must demonstrate that the genetic change is safe to the animal and that food from that animal is safe for human consumption. Genetically engineered animals for research applications are exempt from this regulation to allow for animal drug shipments and labeling, record keeping, and an open path for confidential communication during the development process. To demonstrate successful FDA oversight, Kux highlighted GTC’s Atryn Producing Genetically Engineered Goats, which produce an anti-clotting agent for humans with hereditary clotting disorders in high-risk situations.

Several representatives from various stakeholder organizations were present to provide input to the committee. These ranged from consumer organizations—who asked that the update to the framework mandate all genetically engineered organisms undergo extensive pre- and post-market review—to scientific societies, who requested greater transparency and public engagement to stem public distrust in the biotechnology regulatory process and urged the committee to incorporate the latest scientific evidence into their deliberations.

Dr. Nina Fedoroff

Dr. Nina Fedoroff

Molecular biologist and long-time GSA member Nina Fedoroff, author of  Mendel in the Kitchen: A Scientist’s View on Genetically Modified Food, also addressed the committee, reminding them of previous scientific studies of genetically modified food which found them to have no negative consequences for human consumption. Her complete remarks are reprinted with her permission here. Those interested in these topics are also encouraged to read Pamela Ronald’s 2011 review on genetically modified crops in GENETICS, which discusses the science behind the testing of genetically engineered food. 

If you feel strongly about the way in which genetically engineered organisms are currently regulated and have suggestions for the committee as they update the framework, you should consider responding to the request for information issued by the Office of Science and Technology Policy. Responses must be received by November 13, 2015, at 5 pm ET and can be submitted through the Federal eRulemaking Portal.

Responses are specifically requested to the following questions:

  1. What additional clarification could be provided regarding which biotechnology product areas are within the statutory authority and responsibility of each agency?
  2. What additional clarification could be provided regarding the roles that each agency plays for different biotechnology product areas, particularly for those product areas that fall within the responsibility of multiple agencies, and how those roles relate to each other in the course of a regulatory assessment?
  3. How can Federal agencies improve their communication to consumers, industry, and other stakeholders regarding the authorities, practices, and bases for decision-making used to ensure the safety of the products of biotechnology?
  4. Are there relevant data and information, including case studies, that can inform the update to the CF or the development of the long-term strategy regarding how to improve the transparency, coordination, predictability, and efficiency of the regulatory system for the products of biotechnology?
  5. Are there specific issues that should be addressed in the update of the CF or in the long-term strategy in order to increase the transparency, coordination, predictability, and efficiency of the regulatory system for the products of biotechnology?

 

Related on Genes to Genomes:

 

Also read:

Ronald, P. (2011). Plant genetics, sustainable agriculture and global food security. GENETICS, 188(1), 11-20. doi:10.1534/genetics.111.128553

, , ,

Chloe Poston is the Policy and Communications Manager for the Genetics Society of America where she serves as a liaison to the Public Policy Committee. She has a background in bio-analytical chemistry and science policy.

View all posts by Chloe Poston »

Read more in

  • Thank you, GSA community!

    Thank you for being a member of the Genetics Society of America! As GSA’s current president, I am writing to tell you about Society projects and initiatives that we hope you will find useful in advancing your science and your career. Scientific research is a collaborative and exciting endeavor. Scientific societies like GSA exist to…

  • Collage of 2021 Rosalind Franklin Award recipients

    Where are they now? Rosalind Franklin Young Investigator Award recipients share updates on their research

    Rosalind Franklin Young Investigator Award applications are open–make sure you submit your application or nomination of a colleague by September 30, 2024.

  • University of Minnesota researchers map genome of the last living wild horse species

    The study, published in G3: Genes|Genomes|Genetics, is part of larger conservation efforts to save Przewalski’s horse.

  • Congratulations to the Spring 2024 DeLill Nasser Awardees!

    GSA is pleased to announce the recipients of the DeLill Nasser Award for Professional Development in Genetics for Spring 2024! Given twice a year to graduate students and postdoctoral researchers, DeLill Nasser Awards support attendance at meetings and laboratory courses. The award is named in honor of DeLill Nasser, a long-time GSA supporter and National Science Foundation…

  • Carolyn Damilola headshot

    Carolyn Damilola: an NFS Rising Scientist on a lifelong quest to learn more

    Carolyn Damilola is an NFS Rising Scientist from Nigeria doing respiratory system research and paving the way for scientists from underrepresented communities through mentorship.

  • Text over a blue background image: Apply for up to $2,000 for your project from the Starter Culture Microgrant Program.

    What does a good microgrant proposal look like?

    Members of the Microgrant Review Committee share their tips for a successful proposal.

  • A blurred image of a human face is shown against a dark background.

    The first piece of the facial recognition puzzle

    New research in GENETICS gives a first peek at the molecular pathway involved in recognizing faces.

  • New Senior Editor Amy MacQueen joins GENETICS

    A new senior editor is joining GENETICS in the Genome Integrity and Transmission section. We’re excited to welcome Amy MacQueen to the editorial team.

  • Close up of an adult zebrafish with blue and white stripes in an aquarium with red lighting.

    Block party on the zebrafish sex chromosome

    Research in G3 identifies a gene regulatory block of the zebrafish genome responsible for overseeing the maternal-to-zygotic-transition.

  • Lemna Minor, the common duckweed

    Unraveling the mysteries of duckweed: epigenetic insights from Spirodela polyrhiza

    Research published in G3 offers insight into the impact of DNA methylation on clonal propagation in asexually reproducing plants.

  • Luciano Marraffini headshot

    A microbiologist’s quest to understand CRISPR in bacterial self-defense

    2024 Genetics Society of America Medal recipient Luciano Marraffini determined how CRISPR-Cas systems destroy genetic targets with precision, paving the way for gene editing technology development.

  • Elaine Ostrander headshot

    Unlocking mysteries of trait and disease heritability in dogs

    2024 Edward Novitski Prize recipient Elaine Ostrander, a pioneer of the domestic dog model, discovered numerous genes affecting dog size, morphology, behavior, and disease susceptibility—many of which have relevance in humans.

  • NSF-funded BIO-LEAPS Grant to Support Culture Change in Genetics

    GSA and collaborators Personal Genetics Education & Dialogue and Reclaiming STEM Institute launch NSF-funded BIO-LEAPS project to support culture change in genetics 

    We are thrilled to announce that the Genetics Society of America (GSA) is collaborating with the Personal Genetics Education & Dialogue (PGED) based in the Department of Genetics at Harvard Medical School, and the Reclaiming STEM Institute (RSI) on a Leading Culture Change Through Professional Societies of Biology (BIO-LEAPS) grant from the U.S. National Science…

  • Daman Saluja: Navigating Science and Policy in India

    In the Paths to Science Policy series, we talk to individuals who have a passion for science policy and are active in advocacy through their various roles and careers. The series aims to inform and guide early career scientists interested in science policy. This series is brought to you by the GSA Early Care­er Scientist…

  • Deborah Andrew headshot

    A fly geneticist’s journey into discovering rules of organ development

    2024 George W. Beadle Award recipient Deborah Andrew discovered new genes and pathways in Drosophila salivary gland organogenesis. Now, her work can help optimize cell secretion in therapeutic applications and fight malaria.

  • Małgorzata Gazda's headshot

    Małgorzata Gazda: How receiving the DeLill Nasser Award helped her land her dream job

    Have you ever experienced an event that changes the course of your life, or in this case, your career? Małgorzata (Gosia) Gazda is Assistant Professor at the University of Montreal and in 2022, she received the DeLill Nasser Award for Professional Development in Genetics, which she used to attend and present at the 2022 Population,…

  • Hongyu Zhao joins GENETICS as new Senior Editor

    A new senior editor is joining GENETICS in the Statistical Genetics and Genomics section. We’re excited to welcome Hongyu Zhao to the editorial team.

  • Julio Molina Pineda at TAGC 2024

    GSA Member Julio Molina Pineda Receives DeLill Nasser Award, Shines at TAGC 2024 

    “At any career stage, the GSA membership is an amazing investment for any genetics professional!” Julio Molina Pineda is a PhD Candidate in Cell and Molecular Biology and a Research Assistant at the University of Arkansas, and a Doctoral Academy Fellow at the Lewis Lab. In 2023, Julio was awarded the DeLill Nasser Award for…

  • Ed Grell at his dissecting microscope using ether to anesthetize his flies.

    In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation

    Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…

  • Congratulations to the #Fungal24 Poster Award winners!

    We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…

  • Poster presentation tips for TAGC 2024

    You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…

  • Maximize your TAGC 2024 experience 

    A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…

  • Early Career Leadership Spotlight: Sarah Petrosky

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…

  • TAGC 2024 Early Career Award Winners

    GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024.  Don’t miss the opportunity…

  • Preeminent geneticists recognized with revamped GSA Awards

    In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…

  • Fly Board funds outreach programs to spread the word about Drosophila research

    In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…

  • New members of the GSA Board of Directors: 2024–2026

    We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…

  • New members of the GSA Board of Directors: 2025–2027

    We are pleased to announce the election of six new leaders to the GSA Board of Directors: 2025 Vice President/2026 President Cassandra Extavour Timken Professor of Organismic & Evolutionary Biology and of Molecular & Cellular Biology, Harvard University, and Howard Hughes Medical Institute Investigator “Read this,” he said, “it will change your life.” My undergraduate…

  • Congratulations, Spring 2025 Victoria Finnerty Travel Award recipients!

    The Victoria Finnerty Undergraduate Travel Award supports conference-attendance costs for undergraduate GSA members who are presenting research at the Annual Drosophila Research Conference. #Dros25 will be held in San Diego, CA from March 19–23, 2025. Victoria Finnerty, who died in February 2011, was a long-time member of the Genetics Society of America and served the Drosophila community and the genetics community at large in…

  • Meet embGAN, a revolution for cell lineage studies

    New research in GENETICS reports an automated pipeline for cell lineage tracing that massively reduces manual analysis time.